Janey Ahn - BlackRock Science Secretary
| BST Etf | USD 36.07 0.52 1.42% |
Ms. Janey Ahn is Secretary of Blackrock Science And Technology Trust . She is Director of BlackRock, Inc. since 2009 Vice President of BlackRock, Inc. from 2008 to 2009 Assistant Secretary of the funds in the ClosedEnd Complex from 2008 to 2012.
| Age | 46 |
| Tenure | 13 years |
| Phone | 212 810 5300 |
| Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Janey Ahn Latest Insider Activity
Tracking and analyzing the buying and selling activities of Janey Ahn against BlackRock Science etf is an integral part of due diligence when investing in BlackRock Science. Janey Ahn insider activity provides valuable insight into whether BlackRock Science is net buyers or sellers over its current business cycle. Note, BlackRock Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Janey Ahn 3 days ago Insider Trading |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| William Ogden | Pimco Corporate Income | 75 | |
| Lisa Phelan | Cohen Steers Qualityome | 52 | |
| Christopher Accettella | BlackRock Health Sciences | N/A | |
| Christopher MBA | Tekla Healthcare Investors | N/A | |
| Thomas Kent | Tekla Healthcare Investors | 67 | |
| Albert Laskaj | Cohen And Steers | 43 | |
| Susan Sutherland | Eaton Vance Enhanced | 64 | |
| Frank Fabozzi | BlackRock Health Sciences | 73 | |
| Karen Gilomen | Reaves Utility If | 49 | |
| Lucinda Stebbins | Tekla Healthcare Investors | 73 | |
| Jill Kerschen | Reaves Utility If | 44 | |
| Lisa Phelan | Cohen Steers Reit | 51 | |
| Michael Holland | Reaves Utility If | 75 | |
| Thomas CFA | BlackRock Health Sciences | N/A | |
| John Maney | Pimco Corporate Income | 62 | |
| Kyle CFA | BlackRock Health Sciences | N/A | |
| William Reardon | Tekla Healthcare Investors | 74 | |
| Thomas Faust | Eaton Vance Enhanced | 63 | |
| Dana Devivo | Cohen Steers Total | 39 | |
| Elizabeth Nabel | Tekla Healthcare Investors | 67 | |
| Robert Hubbard | BlackRock Health Sciences | 63 | |
BlackRock Science Tech Money Managers
| Henry Gabbay, Independent Trustee | ||
| Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
| Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
| Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
| Frank Fabozzi, Independent Trustee | ||
| J Holloman, Independent Trustee | ||
| Janey Ahn, Secretary | ||
| John Perlowski, President, Chief Executive Officer, Trustee | ||
| Michael Castellano, Independent Trustee | ||
| Cynthia Egan, Independent Trustee | ||
| Jay Fife, Treasurer | ||
| R Hubbard, Independent Trustee | ||
| Jonathan Diorio, Vice President | ||
| Robert Fairbairn, Trustee | ||
| Neal Andrews, Chief Financial Officer | ||
| Trent Walker, Chief Financial Officer | ||
| Catherine Lynch, Independent Trustee | ||
| Stayce Harris, Independent Trustee | ||
| W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 33.68 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 18.53 % | ||||
| Number Of Shares Shorted | 14.74 K | ||||
| Price To Earning | 5.78 X | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | 5.41 X | ||||
| Number Of Employees | 17 | ||||
| Market Capitalization | 1 B | ||||
| Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.